DNMT3A c.2468G>A ;(p.R823K)

Variant ID: 2-25459815-C-T

NM_022552.4(DNMT3A):c.2468G>A;(p.R823K)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


CD19-directed chimeric antigen receptor T cell therapy in Waldenström macroglobulinemia: a preclinical model and initial clinical experience.

Journal For Immunotherapy Of Cancer
Palomba, M Lia ML; Qualls, David D; Monette, Sebastien S; Sethi, Shenon S; Dogan, Ahmet A; Roshal, Mikhail M; Senechal, Brigitte B; Wang, Xiuyan X; Rivière, Isabelle I; Sadelain, Michel M; Brentjens, Renier J RJ; Park, Jae H JH; Smith, Eric L EL
Publication Date: 2022-02

Variant appearance in text: DNMT3A: R823K
PubMed Link: 35173030
Variant Present in the following documents:
  • jitc-2021-004128.pdf
View BVdb publication page



A full-proteome, interaction-specific characterization of mutational hotspots across human cancers.

Genome Research
Chen, Siwei S; Liu, Yuan Y; Zhang, Yingying Y; Wierbowski, Shayne D SD; Lipkin, Steven M SM; Wei, Xiaomu X; Yu, Haiyuan H
Publication Date: 2022-01

Variant appearance in text: DNMT3A: R823K
PubMed Link: 34963661
Variant Present in the following documents:
  • supp_gr.275437.121_Supplementary_Table_1.xlsx, sheet 3
View BVdb publication page